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Introduction: Although, DNA copy-number alterations (CNAs) have been well documented in a number of
adverse phenotypic conditions, accumulating data suggest that CNAs also occur during physiological
processes. Interestingly, extravillous trophoblasts induce the expression of the transforming, proto-
oncogene ERBB2, which is frequently ampliﬁed in human cancer. However, no data are available to
address whether trophoblast-related ERBB2 expression might also be linked to genomic ampliﬁcation.
Methods: Dual color silver as well as ﬂuorescence in situ hybridization analyses were carried out to
evaluate frequency and degree of ERBB2 gene and chromosome 17 copy numbers in ﬁrst trimester
placental cell columns and isolated trophoblasts. Proliferative EGFRþ and differentiated HLA-Gþ tro-
phoblasts were identiﬁed or separated by means of in situ immunoﬂuorescence co-stainings and mag-
netic beads cell isolation, respectively.
Results: ERBB2 gene ampliﬁcation is detected in approximately 40% of isolated HLA-Gþ trophoblasts.
Although already detectable in EGFRþ cells, the percentage and extent of ERBB2 ampliﬁcation was
markedly increased in HLA-Gþ trophoblasts in situ and after isolation. Accordingly, HLA-Gþ trophoblasts
highly express ERBB2 on protein level. Finally, ERBB2 copy number variations occur independently of
aneuploidy as the majority of ERBB2 amplifying cells were cytogenetically diploid for chromosome 17.
Discussion: ERBB2 gene ampliﬁcation is a frequent event during EVT differentiation. This ﬁnding chal-
lenges the long standing paradigm, which associates gene ampliﬁcation with pathological conditions and
further supports recent evidences suggesting that CNAs are a normal feature of developmental processes.
© 2015 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Somatic cells usually contain a diploid complement of chro-
mosomes and as a consequence two copies of each gene. Whole
chromosome or gene copy number alterations, herein referred to as
copy-number alterations (CNAs), include polyploidy (multiples of
the entire genome complement), aneuoploidy (whole chromosome
gains or losses) and changes in gene copy numbers (under-repli-
cation, ampliﬁcation of subchromosomal regions or single genes).
CNAs are usually associated with adverse impact on the ﬁtness of
an organism such as Down syndrome-associated developmentalnd Fetal-Maternal Medicine,
na, W€ahringer Gürtel 18-20,
x: þ43 1 40400 78420.
ac.at (J. Pollheimer).
Ltd. This is an open access article udisabilities or age-related changes in the brain [1,2]. In addition,
CNAs are considered as distinguished characteristics of cancer ge-
nomes impacting on cell survival, apoptosis, growth and metastasis
[3]. On the other hand, CNAs have also been noticed as part of
normal development and tissue repair [4]. For instance, liver mass
re-generation is associated with the induction of polyploidy in
hepatocytes, which ultimately leads to tissue growth [5]. Moreover,
polyploidy in mouse trophoblast giant cells (TGCs) is central to
proper pregnancy [6,7]. Interestingly, these cells also show large
scale under-replicated regions containing genes involved in cell
adhesion and neurogenesis [8]. Whether human trophoblasts also
show CNAs, and in particular to which extent, is not clear. While
one report suggests that human extravillous trophoblasts (EVTs)
are polyploid [9], another study concludes that EVTs rather develop
aneuploidies instead of multiplying their entire genome [10]. EVTs
emanate from so-called trophoblastic cell columns (CC), by which
the placenta anchors to the decidua. Proliferation occurs at thender the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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differentiate, acquire an invasive phenotype and invade the
decidua. Differentiation into the EVT lineage is characterized by the
induction of speciﬁc marker genes such as integrin alpha 1 and -5,
T-cell factor 4 (TCF4) as well as human leukocyte antigen G (HLA-G)
[11]. EVTs migrate down the lumens of the arteries, or through the
decidual stroma [12]. Proper placental development is central to
reproductive success as anomalies in EVT function have been linked
to several pregnancy pathologies such as preeclampsia [13] and
intrauterine growth restriction [14].
ERBB2 (also known as HER2/Neu) is the most potent oncogene
among the epidermal growth factor receptor family. Although
ERBB2 does not bind a ligand, it is constantly prone to dimerization
and recruits the largest group of phosphotyrosine-binding proteins
among all ERBB members [15]. The ERBB2 gene is located on
chromosome 17 (C17) and is ampliﬁed and overexpressed in about
20e30% of cases of primary human breast cancer, correlating with
adverse patient outcome [16,17]. ERBB2 overexpression impacts on
various cancer cell-associated phenotypes including resistance to
apoptosis, hyperproliferation, increased motility and constitutive
activation of the PI3K/AKT pathway [15]. Moreover, ERBB2-
containing heterodimers are the most potent ERBB complexes as
they show higher growth factor afﬁnities, undergo slow endocy-
tosis and are constantly re-cycled to the cell membrane [18]. On the
other hand, ERBB2 function has also been implicated in physio-
logical processes such as heart [19] or oligodendrocyte [20]
development. In this context it is interesting to note, that previ-
ous studies reported the induction of ERBB2 in human EVTs, while
villous cytotrophoblast (vCTBs) exhibit an EGFRþ/ERBB2 pheno-
type [21e23]. However, no data exist to proof whether ERBB2 gene
ampliﬁcation and, as a consequence, its overexpression is a unique
characteristic of malignancy ormay also be part of normal placental
development.2. Materials and methods
2.1. Tissue collection
First trimester placental tissues (12the13th week, n ¼ 9) were received from
elective pregnancy terminations. The gestational agewas determined by ultrasound.
Specimen were collected with written informed consent and utilization was
approved by the Ethics Committee of the Medical University of Vienna.2.2. Isolation of primary trophoblasts
Primary trophoblasts were isolated from individual placentae by enzymatic
digestion and Percoll gradient centrifugation as described previously [24]. Brieﬂy,
placental villi were dissected, digested two times with 0.125% trypsin (Gibco) and
1.25 mg/ml DNASe I (Sigma Aldrich) for 30 min at 37 C. Obtained trophoblasts
were enriched by Percoll (GE Healthcare) gradient centrifugation. Subsequent to
erythrocyte lysis, cells were cultivated on plastic dishes in DMEM/HAM's F12
medium (Gibco), supplemented with 10% FBS (Biochrom), 0.05 mg/ml gentamicin,
0.5 mg/ml fungizone (both from Gibco) for 40 min to remove ﬁbroblasts. EGFRþ
and HLA-Gþ trophoblasts were isolated by magnetic bead sorting, using EGFR-PE
(Santa Cruz, R-1, mouse, 7.5 mg/ml) and HLA-G-PE (Exbio, MEM-G/9, mouse,
0.1 mg/ml) antibodies, which were labeled with anti-PE micro beads (Miltenyi
Biotec). Cells were collected in Whole Blood Column Kit Elution Buffer (Miltenyi
Biotec) and ﬁxed in Carnoy's ﬁxative (methanol-acetic acid 3:1) for Fluorescence
In Situ Hybridization analyses.2.3. Fluorescence in situ hybridization (FISH)
Fixed cells were air-dried on glass slides and incubated in 2 SSC buffer (Sigma)/
0.5% NP-40 (Calbiochem) for 15 min at 37 C. Subsequent to dehydration in ethanol,
cells were incubated with ZytoLight SPEC HER2/centromere (CEN) 17 Dual Color
Probe (ZYTOVISION) to detect the CEN17 and the ERBB2 gene locus. Hybridization
was carried out overnight at 37 C. Furthermore, slides were washed in 0.4 SSC
buffer/0.3% NP-40 for 2 min at 72 C and in 2 SSC/0.1% NP-40 for 1 min at room
temperature and dehydrated in ethanol. The slides where mounted (Vector Labo-
ratories, VECTASHIELD Mounting Medium with DAPI) and examined under a ﬂuo-
rescence microscope (Axioplan 2, Zeiss; Isis FISH Imaging System V5.5.9,
Metasystems GmbH software).2.4. Immunoﬂourescence stainings
First trimester placental tissues were ﬁxed in 7.5% formaldehyde and
embedded in parafﬁn (Merck). Serial sections were deparafﬁnised and antigen
retrieval was performed in a KOS MircowaveStation (Milestone Srl) using a PT
Module Buffer 1 (pH6, Thermo Fisher Scientiﬁc). Sections were blocked in 0.05%
ﬁsh skin gelatine (SigmaeAldrich) and incubated overnight at 4 C in rabbit anti-
human antibodies directed against EGFR (1:1000; D38B1, Cell Signaling) or ERBB2
(1:1000; 2242, Cell Signaling) and mouse anti-human antibody against HLA-G
(1:100; MEM-G/9, Exbio). A mouse IgG1 (G3A1, Cell Signaling) and a rabbit IgG
antibody (2729, Cell Signaling) were used as negative controls (data not shown).
Subsequently, sections were incubated with goat anti-rabbit or anti-mouse IgG
antibodies conjugated to Alexa Fluor 546 or Alexa 488 (both 2 mg/ml; Molecular
Probes) for 1 h at room temperature. Sections were counterstained with DAPI
(1 mg/ml; Roche Diagnostics) and mounted in Fluoromount-G (Southern
Biotechnology Associates). Images were acquired on a ﬂuorescence microscope
(Olympus BX50, CC12 digital camera, Cell^ P software; Olympus). To make
immunoﬂuorescence (IF) double stainings suitable for color-blind readers, red
images were replaced by magenta (Hex Code: #FF00FF).
2.5. Dual color silver in situ hybridization
Dual color silver in situ hybridization (SISH) on parafﬁn sections of ﬁrst trimester
placental tissues was performed using an automated IHC/ISH slide staining system
(Ventana Benchmark Ultra Full System). Brieﬂy, slides were deparafﬁnised, heat
pretreated with cell conditioner 2 buffer at 86 C for 4 min, followed by protease
digestion using ISH-Protease 3 at 37 C for 8 min. Subsequently, a cocktail of dini-
trophenyl (DNP)-labeled ERBB2(HER2) DNA probe and digoxigenin (DIG)-labeled
chromosome 17 centromere probe (both from Ventana Medical Systems) was added
to the sections for 6 h. The ERBB2(HER2) DNP-labeled probe was detected with a
ERBB2(HER2)-SISH-Ab cocktail (Ventana Medical Systems), including rabbit anti-
DNP and goat anti-rabbit HRP antibodies and visualized as a black signal (silver).
The Chr17 centromere probe was detected by using a CHR 17-Ab cocktail (Ventana
Medical Systems), including mouse anti-DIG and goat anti-mouse alkaline
phosphatase-conjugated antibodies and visualized as a red signal (Napthol, Fast
Red). The slides were counterstained with Hematoxylin II and Bluing reagent (both
from Ventana Medical Systems), mounted in Shandon Consul-Mount (Thermo Sci-
entiﬁc) and analyzed under a brigth-ﬁeld microscope (Olympus BX50, Cell^ P
software).
2.6. Enumeration of hybridization signals
In situ SISH analyses were carried out on 3 placentae (12the13th week).
Subsequent evaluation of genomic ERBB2 copy numbers was performed on 4
representative cell columns per placenta, including 1134 EGFRþ and 2149 HLA-Gþ
trophoblasts. In situ hypridization is prone to truncation effects because parts of
nuclei may be lost during sectioning leading to false positive rates for deletions.
Consequently, SISH counts yielding less then 2 ERBB2 and/or CEN17 signals per
nucleus were excluded from our evaluation. Co-localization of ERBB2 SISH signals
with EGFR or HLA-G protein expression was analyzed in serial placental sections.
For FISH analysis we evaluated ERBB2 and CEN17 probes in 3000 EGFRþ and 3000
HLA-Gþ cells, which were isolated from 3 individual placentae (12the13th week).
Paired signals with distance between them less than the size of one signal were
counted as one.
2.7. Statistical analysis
All statistical analyses were conducted using GraphPad Prism 6. A two-way
ANOVA was used to examine the inﬂuence of the cell tpye on genomic ERBB2
copies followed by Sidak's post hoc test to determine group-speciﬁc differences
(genomic copies and cell type as dependent variables).
3. Results
3.1. Ampliﬁcation of the ERBB2 gene during EVT formation is most
pronounced in HLA-Gþ CC trophoblasts
IF stainings of ﬁrst trimester placental tissues revealed a strong
expression for EGFR at the proximal end of the placental CC. In
contrast, HLA-Gþ distal CC trophoblasts (dCCTs) induce expression
of ERBB2 but are devoid of EGFR, conﬁrming previously published
data [21,22] (Fig. 1A).To test whether the induction of ERBB2 in
HLA-Gþ trophoblasts is linked to genomic ampliﬁcation we
analyzed co-localization of ERBB2 SISH signals with EGFR and HLA-
G protein expression in serial placental sections. Fig. 1B presents
the localization of cells showing 4 ERBB2 gene signals within a
representative trophoblastic CC, indicating an increased occurrence
Fig. 1. The ERBB2 gene is ampliﬁed during EVT differentiation in vivo. (A) IF co-stainings of HLA-G and EGFR or ERBB2 were performed on placental tissue sections (12th week). DAPI
(blue) was used to visualize cell nuclei. Digitally zoomed insets display expression of HLA-G and EGFR at the proximal and distal area of the CC, respectively (i) and co-expression of
HLA-G/ERBB2 at distal regions of the CC (ii). (B) Immunoﬂuorescence co-stainings of EGFR and HLA-G were performed on a placental tissue section (11th week). White dots
represent cells with nuclei showing 4 ERBB2 SISH signals, performed in a serial section. Representative pictures of bright ﬁeld double SISH hybridizations for ERBB2 (black signal)
and CEN17 (red signal) in vCTBs, STs and distal CCTs are shown as high magniﬁcation images. (C) Table shows mean numbers (±SD) of ERBB2 gene copy numbers in EGFRþ and HLA-
Gþ areas of the CC. Four cell columns of each of three different placentae were analyzed. (D) Bars shows the number of genomic copies in HLA-Gþ and EGFRþ areas of the CC,
represented as the percentage of the mean (±SD). Pictures were taken at a 200-fold magniﬁcation. Scale bars represent 50 mm ***, p < 0.0001; *, p < 0.05. dCC, distal cell column;
pCC, proximal cell column; ST, syncytium; VC, villous core; vCTB, villous cytotrophoblast.
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tiotrophoblasts (STs) and vCTBs were mostly diploid for ERBB2
(Fig. 1B). While STs showed no signs for ERBB2 ampliﬁcation we
found a minor population of vCTBs with 4 ERBB2 signals (3.4%),
most likely indicating a cell cycle-dependent 4n chromosome sta-
tus, since these cells also showed 4 CEN17 signals (data not shown).
Close examination of 12 different cell columns showed ERBB2 gene
ampliﬁcation (>2 signals) in 16, 95% EGFRþ and 29,3% HLA-Gþ CC
trophoblasts (CCTs), respectively (Fig. 1C). Two-way ANOVA
conﬁrmed the notion that the trophoblast subtype (EGFRþ or HLA-
Gþ) has a signiﬁcant inﬂuence on the number of genomic ERBB2
copies (p < 0.0001). Subsequent pairwise comparison showed that
nuclei with 2 ERBB2 signals were more frequent in EGFRþ cells. In
contrast, the numbers of nuclei harboring 3 and 4 ERBB2 gene
copies were signiﬁcantly increased in HLA-Gþ trophoblasts. Copy
numbers of more than 4 were exclusively found in HLA-Gþ CCTs
(Fig. 1D).
3.2. Isolated HLA-Gþ trophoblasts frequently harbor ERBB2
ampliﬁcation and to a lesser extent showaneuploidyof chromosome17
Evaluation of gene copy numbers and in particular chromo-
somal karyotypes of parafﬁn embedded tissue sections has been
suggested to be prone to artifacts such as incompletely sectioned
nuclei or poor probe penetration. Therefore, we additionally eval-
uated ERBB2 gene ampliﬁcation in isolated EGFRþ and HLA-Gþ
trophoblasts by FISH analyses (Fig. 2). Prior to FISH analysis, purity
of isolated trophoblast subtypes was controlled by ﬂow cytometry
yielding a purity of 90% EGFRþ or HLA-Gþ cells, respectively (data
not shown). While 11.4% of EGFRþ isolates showed ERBB2 ampliﬁ-
cation, we detected 41% of HLA-Gþ trophoblasts with more than 2
signals for the respective gene locus (Fig. 2A). Again, the extent of
ERBB2 ampliﬁcation was increased in HLA-Gþ cells reaching ERBB2
gene copy numbers of more than 6 per nucleus (Fig. 2A). Two-wayANOVA conﬁrmed that the trophoblast subtype has a signiﬁcant
inﬂuence on the ERBB2 gene copy number (p < 0.0001). Pairwise
comparison revealed that numbers of nuclei with 3, 4 and 5 ERBB2
signals were signiﬁcantly increased in HLA-Gþ trophoblasts, when
compared to EGFRþ cells. The latter population contained signiﬁ-
cantly more cells with 2 ERBB2 gene copies (Fig. 2B). As indicated
above, proliferative cells in G2/M double their DNA content. Hence
a signiﬁcant number of EGRFþ trophoblasts displaying more than
two ERBB2 gene signals might be due to the presence of G2/M
diploids, which have the same DNA content as tetraploid cells (also
see Discussion). Examples of trophoblast nuclei scored as C17
diploid or tetraploid with 2, 4 and 5 ERBB2 signals, respectively are
shown in Fig. 2C. Only a small proportion of both subtypes showed
deletion or loss of the ERBB2 gene loci (EGFRþ: 1.3%, ±0.8%; HLA-
Gþ: 1%, ±0.6%) (Fig. 2D). Moreover, the majority of EGFRþ (97.2%)
and HLA-Gþ (93.9%) cells showed a normal C17 phenotype. In
detail, we detected C17 aneuploidy in 2.8% EGFRþ (1.5% < 1 signal;
1.3% > 2 signals) and in 6.1% HLA-Gþ trophoblasts (2.4% < 2 signal;
3.7% > 2 signals) (Fig. 2D).
4. Discussion
While whole chromosomal gains or losses have already been
described in isolated human trophoblasts [10] no data are available
to address speciﬁc gene copy number alterations during EVT dif-
ferentiation. Our data clearly indicate ampliﬁcation of the ERBB2
gene in HLA-Gþ CCTs and, to a much lesser extent, at proximal
EGFRþ areas of the CC. Accordingly, HLA-Gþ/EGFR CCTs strongly
induce ERBB2 expression on protein level. In addition, our data
indicate only a small proportion of C17 aneuplodies in both
trophoblast subtypes, suggesting that ampliﬁcation of the ERBB2
gene predominantly occurs independently of C17 gains.
In mammals, the greatest differences in terms of gene variability
are observed in the immune and reproductive system suggesting
Fig. 2. Ampliﬁcation of the ERBB2 gene is a more frequent and pronounced event in HLA-Gþ cells and occurs independently of C17 aneuploidy. (A) Table represents absolute cell
counts of ERBB2 gene copy numbers in EGFRþ and HLA-Gþ trophoblasts, isolated from three individual placentae. (B) Table shows cell counts and percentages of EGFRþ and HLA-Gþ
trophoblasts with normal and abnormal C17 karyotypes. In addition, ERBB2 gene copy numbers of aneuploid trophoblasts are indicated. C) Representative pictures of isolated
trophoblasts hybridized with a SPEC HER2 (green signal)/CEN17 (red signal) dual color probe. The DAPI counterstain is shown in blue. Pictures were taken at a 1000-fold
magniﬁcation. D) Data represent the average number of genomic ERBB2 copies in isolated EGFRþ and HLA-Gþ trophoblasts (±SD). ***, p < 0.0001; **, p < 0.001*, p < 0.05.
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Recent studies indicated that the development of CNAs may be an
effective way to adapt to selective pressure [1]. For instance,
experimental evolution studies showed that CNAs allow microor-
ganisms to survive under selective stress, provoked for instance by
antibiotic treatment in E. coli [27] or growth limiting conditions in
budding yeast [28]. Another interesting outcome of the latter study
was that stress-induced chromosome copy number variations are
transient. When cultivated under elevated temperature, diploid
budding yeast achieves heat tolerance by developing trisomy ofchromosome 3. However, when this condition was prolonged over
1000 generations, trisomy of chromosome 3 was replaced by the
overexpression of speciﬁc genes that mediate heat tolerance. EVT-
associated ERBB2 gene ampliﬁcation might underlie similar adap-
tive mechanisms since only a small proportion of trophoblasts
showed whole C17 gains. Therefore, ampliﬁcation of the ERBB2
gene may represent an adaptive, cost-efﬁcient mechanism, inde-
pendent of large-scale CNAs such as aneuploidy. In analogy to this,
it would be interesting to study the genomic copy number status of
other EVT-enriched genes including ADAM12 [11], TCF4 [29] or
G. Meinhardt et al. / Placenta 36 (2015) 803e808 807HLA-G [30]. A similar approach in differentiating neural progenitor
cells showed up to 93 ampliﬁed and 30 deleted chromosome re-
gions [31]. Strikingly, the same authors report a signiﬁcant overlap
of ampliﬁed regions between neural progenitors and malignant
tumor cells derived from astrocytes. In this context, it is interesting
to note that ERBB2 gene ampliﬁcation has been reported in cases of
persistent gestational trophoblastic disease [32].
There are several mechanisms by which a cell is able to meet
increased protein-synthesis needs including upregulation of tran-
scription, upregulation of translation or gene ampliﬁcation. In
support of the latter, quantitative proteomic analysis in yeast and
human cells showed that alterations in gene copy number provoke
changes in protein levels in the vast majority of studies [33e35].
Along these line of evidences, ERBB2 protein expression in
trophoblastic CC is strongly associated with the degree of gene
ampliﬁcation. In detail, we found about 11% EGFRþ and 40% HLA-Gþ
cells, which showed more than 2 ERBB2 gene signals. As cell divi-
sion is restricted to the proximal region of the CC [22], detection of
gene ampliﬁcation in EGFRþ trophoblasts might be biased due to
the presence of mitotic diploid cell nuclei. Indeed, about half of the
EGFRþ trophoblasts with 4 ERBB2 signals also showed 4 CEN17
signals, indicating a cell cycle-dependent 4n chromosome state in
these cells. Indeed, the mean percentage of vCTBs with 4 ERBB2
signals (3.4%) is comparable to reported percentages for mitotic
villous trophoblasts [36]. In contrast, only 1% of all HLA-Gþ cells,
which showed 4 ERBB2 gene signals also yielded a similar number
of CEN17 counts. Approximately, 3% of EGFRþ and 6% of HLA-Gþ
trophoblasts showed C17 gain or losses. This ﬁnding is in accor-
dance with a previous report demonstrating that second trimester
HLA-Gþ trophoblasts acquire aneuoploid genomes [10]. Interest-
ingly, the authors of this study also identiﬁed C17 to be involved in
aneuploidy, albeit at a much higher degree of about 30%. This
discrepancy to our ﬁndings is explainable by the fact that Weier
et al. analyzed second trimester trophoblasts, which show, ac-
cording to the same authors, a strong increase in aneuploidy rates
when compared to ﬁrst trimester [10].
On the other hand, mice TGCs amplify their DNA in the absence
of karyokinesis and cytokinesis by the formation of cohesin-linked
polytene chromosomes [37]. Since polytene chromosomes are not
separated, TGCs contain a diploid number of centromeric hybridi-
zation signals [38]. This implicates that ampliﬁcation of the ERBB2
gene in human EVTs could also be due to chromosomal polyteny
rather than ampliﬁcation of a single gene. To address this possi-
bility, further studies are necessary involving additional methods
such as determination of whole DNA content or additional hy-
bridization probe strategies.
The positive correlation between ERBB2 gene ampliﬁcation and
EVT differentiation is, as expected, reﬂected by protein expression.
In addition, we detected a signiﬁcant number of HLA-Gþ cells with
a diploid number of ERBB2 signals indicating alternative mecha-
nism, which may trigger ERBB2 expression during EVT differenti-
ation. In this context, it is well-established that overexpression of
ERBB2, can be caused either by gene ampliﬁcation, mutation or
excessive promoter activity [39]. Here, our own and previously
published data clearly indicate that ERBB2 protein expression is
restricted to differentiated HLA-Gþ trophoblasts [21,22]. Notably,
ERBB2 overexpression is sufﬁcient to cause transformation of hu-
man stroma cells [40] and vice versa drug-mediated inactivation of
ERBB2 has been proven to signiﬁcantly delay mortality of cancer
patients [41]. Its restrictive expression to differentiated, non-
dividing HLA-Gþ trophoblasts may therefore be a safety mecha-
nism to avoid the risk of malignant transformation. Interestingly,
apart from its function as a potent trigger of cancer cell prolifera-
tion, ERBB2 has also been linked to cancer cell motility [42]. It may
therefore very well be, that the upregulation of ERBB2 in HLA-Gþtrophoblasts triggers motility in these cells. In addition, ERBB2
seems to drive cellular differentiation in physiological settings. For
instance, knockout studies in mice demonstrated that ERBB2
transduces a terminal differentiation signal to facilitate oligoden-
drocyte development [20]. Along this line of evidence it is inter-
esting to note that ERBB2 was found to regulate expression of
integrin alpha 5 [43], a marker for terminally differentiated EVTs in
humans [44].
In summary, we report that the EVT differentiation process is
accompanied by the ampliﬁcation of the proto-oncogene ERBB2.
This ﬁnding supports recent studies, which suggest CNA as part of
normal trophoblast development.
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